Despite the strong associations between body weight and the risks of stroke or coronary heart attack, some studies have found that overweightness is not necessarily associated with poor prognosis or higher mortality, a phenomenon known as the “obesity paradox” [35,36] in which the protection of FGF21 could play a critical role [37]. Here, FGF21 is linked to stroke disorder.